| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0005 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0007 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |